Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

The Ottawa Hospital Regional Cancer Centre

3 abstracts

Abstract
A multi-centre, single arm, phase 2 trial of pembrolizumab in treatment-naïve patients with carcinoma of unknown primary site.
Org: Edmonton, AB, Canada, University of Ottawa, The Ottawa Hospital Regional Cancer Centre,
Abstract
Correlating peptidylglycine alpha-amidating monooxygenase (PAM) expression with clinicopathologic variables in gastrointestinal (GI) neuroendocrine tumors (NETs).
Org: The Ottawa Hospital Research Institute, Ottawa Hospital Research Institute, The Ottawa Hospital Regional Cancer Centre, Baylor College of Medicine, The Ottawa Hospital Cancer Centre,
Abstract
Real world sequence of peptide receptor radionucleotide therapy (PRRT) and chemotherapy in patients with metastatic pancreatic neuroendocrine tumors (pNETs).
Org: University of Ottawa, London Health Science Centre, The Ottawa Hospital Research Institute, Western University, London Health Sciences Centre,